| Fungal Infection |
1 |
1 |
| Skin and Soft Tissue Infection |
0 |
0.98 |
| Dermatophytosis |
0 |
0.77 |
| New York |
0 |
0.53 |
| Onychomycosis |
0 |
0.52 |
| Tinea Corporis |
0 |
0.52 |
| Dermatitis |
0 |
0.39 |
| Antifungal |
0 |
0.29 |
| COVID-19 |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.15 |
| Alabama |
0 |
0.14 |
| Gluteal Region |
0 |
0.14 |
| Hospital |
0 |
0.14 |
| Biopsy |
0 |
0.1 |
| Cervical Region |
0 |
0.1 |
| Drug Interaction |
0 |
0.1 |
| Hair |
0 |
0.1 |
| Heart Failure (HF) |
0 |
0.1 |
| Massachusetts |
0 |
0.1 |
| Steroids |
0 |
0.1 |
| Travel Medicine |
0 |
0.1 |
| Centers for Disease Control and Prevention |
0 |
0.08 |
| Sexually Transmitted Infection |
0 |
0.08 |
| Atopic Dermatitis |
0 |
0.07 |
| Congestive Heart Failure |
0 |
0.07 |